Immunological basis for rapid progression of diabetes in older NOD mouse recipients post BM-HSC transplantation

Nan Wang, Narendiran Rajasekaran, Tieying Hou, Claudia Macaubas, Elizabeth D. Mellins

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Type I diabetes (T1D), mediated by autoreactive T cell destruction of insulin-producing islet beta cells, has been treated with bone marrow-derived hematopoietic stem cell (BM-HSC) transplantation. Older non-obese diabetic (NOD) mice recipients (3m, at disease-onset stage) receiving syngeneic BM-HSC progressed more rapidly to end-stage diabetes post-transplantation than younger recipients (4-6w, at disease-initiation stage). FACS analyses showed a higher percentage and absolute number of regulatory T cells (Treg) and lower proportion of proliferating T conventional cells (Tcon) in pancreatic lymph nodes from the resistant mice among the younger recipients compared to the rapid progressors among the older recipients. Treg distribution in spleen, mesenteric lymph nodes (MLN), blood and thymus between the two groups was similar. However, the percentage of thymic Tcon and the proliferation of Tcon in MLN and blood were lower in the young resistants. These results suggest recipient age and associated disease stage as a variable to consider in BM-HSC transplantation for treating T1D.

Original languageEnglish (US)
Article numbere0128494
JournalPLoS ONE
Issue number5
StatePublished - May 28 2015
Externally publishedYes

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Immunological basis for rapid progression of diabetes in older NOD mouse recipients post BM-HSC transplantation'. Together they form a unique fingerprint.

Cite this